A 12-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Severe Nasolabial Folds

por Ascher, Benjamin, Bayerl, Christiane, Kestemont, Philippe, Rzany, Berthold, Edwartz, Carolina, Podda, Maurizio
Publicado 2017

Ethnicity and Nonsurgical Rhinoplasty

por Ziade, Georges, Mojallal, Ali, Ho-Asjoe, Mark, Arenas, Juan Carlos, Ascher, Benjamin
Publicado 2022

Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-La...

por Kestemont, Philippe, Hilton, Said, Andriopoulos, Bill, Prygova, Inna, Thompson, Catherine, Volteau, Magali, Ascher, Benjamin
Publicado 2021

Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment

por Hilton, Said, Kestemont, Philippe, Sattler, Gerhard, Volteau, Magali, Thompson, Catherine, Andriopoulos, Bill, Prygova, Inna, Berg, Anna-Karin, Ascher, Benjamin
Publicado 2022

The Effect of Hybrosome (Umbilical Cord Blood Exosome–Liposome Hybrid Vesicles) on Human Dermal Cells In Vitro

por Koçak, Polen, Unsal, Naz, Canikyan, Serli, Kul, Yaren, Cohen, Steven R, Tiryaki, Tunç, Duncan, Diane, Schlaudraff, Kai-Uwe, Ascher, Benjamin, Tiryaki, Teodor Eren
Publicado 2023

Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Gl...

por Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Publicado 2019

Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial

por Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Publicado 2020

Response to “Facial Line Outcomes (FLO-11) and Facial Line Satisfaction Questionnaire (FLSQ) Meet FDA PRO Guidance”

por Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Publicado 2020

Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moder...

por Ascher, Benjamin, Rzany, Berthold, Kestemont, Philippe, Hilton, Said, Heckmann, Marc, Bodokh, Isaac, Noah, Ernst Magnus, Boineau, Dominique, Kerscher, Martina, Volteau, Magali, Le Berre, Philippe, Picaut, Philippe
Publicado 2021

PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data

por Solish, Nowell, Ascher, Benjamin, Avelar, Rui L, Bertucci, Vince, Bodokh, Isaac, Carruthers, Jean, Cartier, Hugues, Delmar, Henry, Denfeld, Ralf, Heckmann, Marc, Hedén, Per, Hilton, Said, Inglefield, Christopher, Ogilvie, Patricia, Rzany, Berthold-Josef, Sattler, Gerhard, Sebastian, Michael, Swift, Arthur, Trévidic, Patrick
Publicado 2022